Red cell transfusion: An essential factor for patient prognosis in surgical critical illness?

Shock

Volumn 28, Issue 2, 2007, Pages 165-171

  Rüttinger, Dominik ^a   Wolf, Hilde ^a   Küchenhoff, Helmut ^b   Jauch, Karl Walter ^a   Hartl, Wolfgang H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Length of stay; Mortality; Red cell transfusion; Surgical intensive care

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DATA ANALYSIS; DISEASE SEVERITY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT;

CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; PROGNOSIS; SURGICAL PROCEDURES, OPERATIVE;

EID: 34547666639     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31803df84d     Document Type: Article

References (45)

1. Madjdpour C, Heindl V, Spahn DR: Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol 72:283-298, 2006.
2. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL: Transfusion of the injured patient: proceed with caution. Shock 21:291-299, 2004.
3. Napolitano L: Cumulative risks of early red blood cell transfusion. J Trauma 60(suppl):S26-S34, 2006.
4. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, Andermahr J, Neugebauer EA: Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 20:497-502, 2003.
5. Raghavan M, Marik PE: Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 127:295-307, 2005.
6. Blajchman MA: The clinical benefits of the leukoreduction of blood products. J Trauma 60(suppl):S83-S90, 2006.
7. Croce MA, Tolley EA, Claridge JA, Fabian TC: Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 59:19-23, 2005.
8. Mostafa G, Gunter OL, Norton HJ, McElhiney BM, Bailey DF, Jacobs DG: Age, blood transfusion, and survival after trauma. Am Surg 70:357-363, 2004.
9. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS: Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68:566-572, 2002.
10. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM: Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898-905, 2003.
11. Robinson WP 3rd, Ahn J, Stiffler A, Rutherford EJ, Hurd H, Zarzaur BL, Baker CC, Meyer AA, Rich PB: Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. J Trauma 58:437-444, 2005.
12. Moore FA, Moore EE, Sauaia A: Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132:620-624, 1997.
13. Miller PR, Croce MA, Kilgo PD, Scott J, Fabian TC: Acute respiratory distress syndrome in blunt trauma: identification of independent risk factors. Am Surg 68:845-850, 2002.
14. Palmieri TL, Caruso DM, Foster KN, Cairns BA, Peck MD, Gamelli RL, Mozingo DW, Kagan RJ, Wahl W, Kemalyan NA, et al.: American Burn Association Burn Multicenter Trials Group. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med 34:1602-1607, 2006.
15. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH: Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34:1608-1616, 2006.
16. Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curiel A, Camacho-Larana P, Rincon-Ferrari MD, Ordonez-Fernandez A, Flores-Cordero JM, Loscertales-Abril J: Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 28:935-940, 2000.
17. Vamvakas EC, Carven JH: Allogeneic blood transfusion and postoperative duration of mechanical ventilation. Transfusion 41:885-892, 2001.
18. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S: Determinants of hospital mortality after coronary artery bypass grafting. Chest 115:1598-1603, 1999.
19. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC: Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33:1191-1198, 2005.
20. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C: Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 30:2249-2254, 2002.
21. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ: The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32:39-52, 2004.
22. Shorr AF, Duh MS, Kelly KM, Kollef MH: CRIT Study Group. Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med 32:666-674, 2004.
23. Shorr AF, Jackson WL, Kelly KM, Fu M, Kollef MH: Transfusion practice and blood stream infections in critically ill patients. Chest 127:1722-1728, 2005.
24. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D: ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 288:1499-1507, 2002.
25. Carson JL, Hill S, Carless P, Hebert P, Henry D: Transfusion triggers: a systematic review of the literature. Transfus Med Rev 16:187-199, 2002.
26. McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E, Blajchman MJ: Canadian Critical Care Trials Group. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 57:563-568, 2004.
27. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T: EPO Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827-2835, 2002.
28. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345: 1230-1236, 2001.
29. Adamina M, Guller U, Weber WP, Oertli D: Propensity scores and the surgeon. Br J Surg 93:389-394, 2006.
30. Cook R, Cook D, Tilley J, Lee K, Marshall J: Canadian Critical Care Trials Group. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 29:2046-2050, 2001.
31. Cabre L, Mancebo J, Solsona JF, Saura P, Gich I, Blanch L, Carrasco G, Martin MC: and the Bioethics Working Group of the SEMICYUC. Multicenter study of the multiple organ dysfunction syndrome in intensive care units: the usefulness of Sequential Organ Failure Assessment scores in decision making. Intensive Care Med 31:927-933, 2005.
32. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638-1652, 1995.
33. Hazinski MF, Iberti TJ, MacIntyre NR, Parker MM, Tribett D, Prion S, Chmel H: Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. Am J Crit Care 2:224-235, 1993.
34. Lowenkron SE, Niederman MS: Definition and evaluation of the resolution of nosocomial pneumonia. Semin Respir Infect 7:271-281, 1992.
35. Nathens AB, Rotstein OD: Therapeutic options in peritonitis. Surg Clin North Am 74:677-692, 1994.
36. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167-172, 2000.
37. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873, 2004.
38. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 40:409-417, 1999.
39. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC: Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock 13:29-33, 2000.
40. Aiboshi J, Moore EE, Ciesla DJ, Silliman CC: Blood transfusion and the twoinsult model of post injury multiple organ failure. Shock 15:302-306, 2001.
41. Prins HA, Houdijk AP, Nijveldt RJ, Teerlink T, Huygens P, Thijs LG, van Leeuwen PA: Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock 16:113-115, 2001.
42. Nathens AB, Nester TA, Rubenfeld GD, Nirula R, Gernsheimer TB: The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 26:342-347, 2006.
43. Hebert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, et al.: Leukoreduction Study Investigators. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 289:1941-1949, 2003.
44. Gramm J, Smith S, Gamelli RL, Dries DJ: Effect of transfusion on oxygen transport in critically ill patients. Shock 5:190-193, 1996.
45. Klein HG: Blood avoidance for the critically ill: another blow to liberalism? Crit Care Med 34:2013-2014, 2006.